MML has successfully exited its investment in Luneau Technology, a global leader in ophthalmological diagnostic equipment, refractive optometry equipment and equipment for opticians. The Group directly operates in 11 countries, with partners in more than 75 countries, selling its products worldwide.
Luneau Technology Group (Luneau Tech), one of the global leading players in the optical medical equipment market (optometric and edging products) has finalised a strategic investment in Chinese partner Ming Sing Optical (MSOC).
MML backed Luneau Technology Group (Luneau), led by CEO Dr Marc Abitbol, has acquired the French assets of Haag Streit further consolidating Luneau’s position as a leading player in the visual healthcare and ophthalmology markets.
MML Capital Partners has invested into The Luneau Technology Group (“Luneau”). Luneau is a world leader in the supply of diagnostic equipment, analysis and testing in ophthalmology, refractive optometry equipment and cutting equipment and mounting opticians. Luneau operates in 9 countries, and sells into over 100.